Replies to post #65921 on Savvy Trades and Investments

[Knowledge is King]

SRTS down 28%; B.Riley target cut from $14 to $5.50

[2morrowsGains]

SRTS...More growing pains...Sales came in short again...And they had tariff issues so no sales to China for the quarter. They are trying to lock in a contract with SkinCure. And they are still hoping to get three more Sculptra units shipped by year-end.
On a brighter note, these guys are great with their cash. Low cash burn, and no debt.
Sensus just received clearance from Korea and they are working on getting clearance in Brazil and India.
The stock got hammered today. My holdings are not as large as they once were, but I still like the company and I think there's huge growth over the next few years. Trading at $4 and dipped into the $3's today. It'll come back.